CNS Vital Signs

What CNS Vital Signs does

CNS Vital Signs, LLC is a Morrisville, North Carolina-based private company founded in 2002 that builds computerized neurocognitive and behavioral assessment software for clinicians, hospitals, and academic researchers. Its core product is the BRIEF-CORE battery, a validated seven-subtest protocol (Verbal Memory, Visual Memory, Finger Tapping, Symbol Digit Coding, Stroop, Shifting Attention, Continuous Performance) measuring eleven cognitive domains including composite memory, executive function, processing speed, reaction time, and cognitive flexibility, with millisecond-precision scoring and embedded performance validity indicators for detecting invalid effort or malingering. The platform is delivered through multiple channels: a local desktop product (VS4) for Windows and Mac, a cloud-based web testing product (CNSVS Online), a research-focused product (Cognitrax), a free concussion screening product (Concussion Vital Signs), a remote/telehealth testing module, an ADHD assessment tool, and a consumer-facing brain age tool (Know Your Brain Age). The platform is FDA registered as a medical device, SOC 2 Type 2 compliant, encrypted at 256-bit and hosted on AWS, supports tests in 60 languages, and is normed against a sample of 1,508 healthy individuals aged 8 to 90.

CNS Vital Signs operates a usage-based revenue model, charging $35 per test session across VS4, CNSVS Online, and Cognitrax (with the latter discounted to $25 for research), a $55 one-time hardware fee for a custom response keyboard, and custom-priced professional services for clinical trial and research programming. There are no setup fees, no service contracts, free software and upgrades, free 5-session trials on registration, and Concussion Vital Signs is provided free of charge. Its go-to-market combines product-led self-service (website demo, free trial, account-based e-commerce on the platform), inside sales (phone purchasing, purchase-order support), and an event-driven motion of 30-minute informational and 1-hour customized training webinars.

The company has a small (1-10) employee footprint, no disclosed institutional investors or funding rounds, and depends on long-tenured clinical validation (a 2006 Archives of Clinical Neuropsychology peer-reviewed validation study) and the FDA registration as primary anchors for credibility. Its primary customer segments are independent clinical practices, hospitals and health systems, and academic/CRO researchers running clinical trials; patient-facing intake is supported through the remote testing portal in five languages.

Name

CNS Vital Signs

Legal name

CNS Vital Signs, LLC

Website

https://cnsvs.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1–10 employees

Short description

CNS Vital Signs, a Morrisville, NC-based private LLC, develops FDA-registered computerized neurocognitive assessment software (BRIEF-CORE battery measuring 11 cognitive domains) sold on a usage-based $35-per-test model to clinicians, hospitals, and academic researchers.

Ownership category

akta.pro rank

Product category

Clinical Neurocognitive Assessment Software

NAICS

Medical and Diagnostic Laboratories (62151)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

akta.pro secondary industries

Neurology Telemedicine Platforms (HLALAGAC), Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)

Keywords

• Computerized neurocognitive testing
• Cognitive assessment software
• Concussion screening tools
• Behavioral health assessments
• Telemedicine cognitive testing

Headquarters

HQ city

Morrisville

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Per-Test Assessment Sessions: Core revenue from selling individual neurocognitive test sessions at $35 per assessment. Volume discounts available for bulk purchases (10+ sessions). Assessment sessions are consumed when tests are completed. Free rating instruments included on all products.
2. Research and Custom Programming Services: Clinical trials, research projects, and custom programming priced according to scope of work. Special pricing for students, interns, residents, fellows, and academic/government groups conducting research of scientific merit.
3. Hardware Sales: Custom keyboard available for purchase at $55, including shipping and handling.
4. Product Licensing: Multiple product lines including VS4, CNSVS Online Web, Cognitrax ($25/test), and Concussion Vital Signs (free). Products available in 60 neurocognitive testing languages.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

CNS Vital Signs sells FDA-registered, SOC 2 Type 2 compliant computerized neurocognitive and behavioral assessment platforms that combine a proprietary seven-test BRIEF-CORE battery with clinical rating instruments to measure eleven cognitive domains with millisecond precision. Offerings span local desktop software (VS4), cloud-based web testing (CNSVS Online), research-grade testing (Cognitrax), and a free concussion screening product (Concussion Vital Signs), each using a pay-per-session model with telehealth-enabled remote testing and EMR export. Free 5-trial assessments, training webinars, and a $55 custom keyboard round out the transaction-based product set.

Product overview

CNS Vital Signs provides a broad-spectrum computerized neurocognitive testing platform with four main products: VS4 (local desktop software for Windows/Mac at $35/test), CNSVS Online (web-based testing platform at $35/test), Cognitrax (research-focused testing at $25/test), and Concussion Vital Signs (free concussion screening). The platform delivers a BRIEF-CORE battery of seven neurocognitive subtests measuring 11 cognitive domains including memory, attention, executive function, and processing speed. Additional offerings include Remote Testing for telehealth, an ADHD Assessment Tool, and Know Your Brain Age. All products feature automated scoring, age-adjusted normative comparisons, performance validity indicators, and EMR export capabilities. Pricing follows a simple model with no startup fees, free software upgrades, and volume discounts available. The platform is SOC 2 Type 2 compliant.

Differentiator

Problem solved

Functional benefit

Brands

• VS4: Desktop software for Windows and Mac - local neurocognitive testing platform with data stored locally
• CNSVS Online
• Cognitrax
• Concussion Vital Signs
• Remote Testing

Products and services

• VS4 Desktop neurocognitive testing software for Windows 10+ and Mac OS 10.6.8+ (Intel) that runs locally without internet once installed, stores all data on the clinic's hard drive, optionally backs up to CNSVS Online servers, and generates immediate reports for clinicians and researchers using the BRIEF-CORE battery at $35 per assessment.
• CNSVS Online (Web Testing) Cloud-based web testing platform accessible from any internet-connected computer with no software installation required; reports are automatically stored in the user's account and the system supports the full BRIEF-CORE battery plus rating instruments at $35 per assessment session.
• Cognitrax Research-focused neurocognitive testing platform priced at $25 per assessment, designed for clinical trials and research projects with standard computerized neurocognitive testing, telemedicine capability, embedded validity indicators, and unlimited alternate forms.
• Concussion Vital Signs (CVS) Free concussion assessment tool that delivers a neurocognitive testing procedure with telemedicine support, embedded performance validity indicators, real-time reports, and is reimbursable when used in clinical workflows.
• Remote Testing Platform Telehealth-enabled testing service accessed via testing.cnsvs.com that lets clinicians generate 8-character remote test codes sent to patients; tests expire after 7 days and the patient UI is available in English, Spanish, French, Portuguese, and German.
• Know Your Brain Age (KYBA) Cognitive aging assessment tool for measuring brain health and tracking neurocognitive changes over time, offered under a separate consumer-facing website (knowyourbrainage.com).
• CNS Vital Signs Custom Keyboard Proprietary physical input device for administering CNS Vital Signs tests, sold one-time for $55 including shipping and handling through the customer account login.
• Research and Custom Programming Services Professional services for clinical trials, research projects, and custom programming, priced according to scope of work, with special academic/government pricing for students, interns, residents, fellows, and academic or government groups conducting research of scientific merit.

Quantifiable outcome

• Millisecond precision in measuring cognitive domains including reaction time and processing speed
• +3 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ImPACT Applications: ImPACT Applications is the dominant computerized neurocognitive testing platform for concussion assessment, used widely in sports, military, and clinical settings. It is a direct competitor to CNS Vital Signs' Concussion Vital Signs and broader cognitive battery, serving the same clinician customer base with similar reimbursable procedures.
• Cogstate: Cogstate provides computerized cognitive assessment batteries for clinical trials and healthcare, with strong positioning in pharmaceutical research and concussion. It directly competes with CNS Vital Signs' Cognitrax product in the research/CRO segment and overlaps in clinical concussion and oncology cognition use cases.
• Cambridge Cognition: Cambridge Cognition develops computerized cognitive testing for pharmaceutical trials, research, and clinical use, with products like CANTAB. It competes head-to-head with CNS Vital Signs in clinical trials, ADHD, and CNS endpoints and is a like-for-like competitor in computerized neurocognitive batteries.

Emerging players

• BrainCheck: BrainCheck is a digital cognitive assessment platform offering rapid, tablet-based neurocognitive testing for concussion, dementia, and ADHD in clinical workflows. It overlaps with CNS Vital Signs in use cases (concussion, MCI, ADHD) but emphasizes a more modern, mobile-native UX and EHR integration.
• Savonix: Savonix delivers a digital neurocognitive assessment platform focused on cognitive health screening and tracking across clinical and consumer populations. It is an emerging competitor targeting similar clinician and research users with a mobile-first, AI-augmented alternative to legacy computerized batteries.
• Altoida: Altoida uses augmented reality and AI on smartphones to detect cognitive impairment and predict neurological disease risk. It targets overlapping use cases (MCI, Alzheimer's risk, cognitive screening) with a differentiated AR-based modality, competing for clinician and pharma attention alongside CNS Vital Signs.
• Lumos Labs (Lumosity): Lumosity is a consumer-facing cognitive training and assessment platform with research-grade tools. While primarily B2C, it overlaps thematically with CNS Vital Signs' cognitive measurement domain and KYBA consumer product, and competes for mindshare on consumer brain health.
• Neurotrack: Neurotrack develops digital cognitive assessment and memory screening tools focused on Alzheimer's and age-related cognitive decline. It overlaps with CNS Vital Signs' MCI, healthy aging, and dementia-related use cases and represents an emerging modality competitor in cognitive screening.

Broad incumbents

• Pearson Clinical (Q-global / Q-interactive): Pearson is a large incumbent assessment publisher whose Q-interactive and Q-global platforms digitize classic neuropsychological instruments. It competes broadly with CNS Vital Signs in clinician-facing cognitive assessment but offers a much broader portfolio across educational and psychological testing.
• Psychological Assessment Resources (PAR): PAR is an established publisher of psychological and neuropsychological assessments, including computerized tools used by clinicians. It competes with CNS Vital Signs in cognitive and behavioral assessment for psychologists and healthcare providers, but as part of a broader assessment catalog.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CNS Vital Signs